| Clinical effect of point mutations in myelodysplastic syndromes R Bejar, K Stevenson, O Abdel-Wahab, N Galili, B Nilsson, ... New England Journal of Medicine 364 (26), 2496-2506, 2011 | 1906 | 2011 |
| Evolution and impact of subclonal mutations in chronic lymphocytic leukemia DA Landau, SL Carter, P Stojanov, A McKenna, K Stevenson, ... Cell 152 (4), 714-726, 2013 | 1610 | 2013 |
| SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia L Wang, MS Lawrence, Y Wan, P Stojanov, C Sougnez, K Stevenson, ... New England Journal of Medicine 365 (26), 2497-2506, 2011 | 1380 | 2011 |
| Recurrent BRAF mutations in Langerhans cell histiocytosis G Badalian-Very, JA Vergilio, BA Degar, LE MacConaill, B Brandner, ... Blood, The Journal of the American Society of Hematology 116 (11), 1919-1923, 2010 | 1214 | 2010 |
| TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients R Bejar, A Lord, K Stevenson, M Bar-Natan, A Pérez-Ladaga, J Zaneveld, ... Blood, The Journal of the American Society of Hematology 124 (17), 2705-2712, 2014 | 622 | 2014 |
| Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes R Bejar, KE Stevenson, BA Caughey, O Abdel-Wahab, DP Steensma, ... Journal of clinical oncology 30 (27), 3376, 2012 | 552 | 2012 |
| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 455 | 2020 |
| Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation R Bejar, KE Stevenson, B Caughey, RC Lindsley, BG Mar, P Stojanov, ... Journal of clinical oncology 32 (25), 2691, 2014 | 451 | 2014 |
| Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia M Rajasagi, SA Shukla, EF Fritsch, DB Keskin, D DeLuca, E Carmona, ... Blood, The Journal of the American Society of Hematology 124 (3), 453-462, 2014 | 440 | 2014 |
| A targeted mutational landscape of angioimmunoblastic T-cell lymphoma O Odejide, O Weigert, AA Lane, D Toscano, MA Lunning, N Kopp, S Kim, ... Blood, The Journal of the American Society of Hematology 123 (9), 1293-1296, 2014 | 427 | 2014 |
| Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia DA Landau, K Clement, MJ Ziller, P Boyle, J Fan, H Gu, K Stevenson, ... Cancer cell 26 (6), 813-825, 2014 | 377 | 2014 |
| Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease S Sarantopoulos, KE Stevenson, HT Kim, CS Cutler, NS Bhuiya, ... Blood, The Journal of the American Society of Hematology 113 (16), 3865-3874, 2009 | 367 | 2009 |
| Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000) LB Silverman, KE Stevenson, JE O'Brien, BL Asselin, RD Barr, L Clavell, ... Leukemia 24 (2), 320-334, 2010 | 359 | 2010 |
| The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells IM Min, G Pietramaggiori, FS Kim, E Passegué, KE Stevenson, AJ Wagers Cell stem cell 2 (4), 380-391, 2008 | 349 | 2008 |
| The public repository of xenografts enables discovery and randomized phase II-like trials in mice EC Townsend, MA Murakami, A Christodoulou, AL Christie, J Köster, ... Cancer cell 29 (4), 574-586, 2016 | 328 | 2016 |
| Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia DJ DeAngelo, KE Stevenson, SE Dahlberg, LB Silverman, S Couban, ... Leukemia 29 (3), 526-534, 2015 | 326 | 2015 |
| Postinduction dexamethasone and individualized dosing of Escherichia coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute … LM Vrooman, KE Stevenson, JG Supko, J O'Brien, SE Dahlberg, ... Journal of clinical oncology 31 (9), 1202, 2013 | 325 | 2013 |
| High levels of B-cell activating factor in patients with active chronic graft-versus-host disease S Sarantopoulos, KE Stevenson, HT Kim, NS Bhuiya, CS Cutler, ... Clinical Cancer Research 13 (20), 6107-6114, 2007 | 304 | 2007 |
| Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium protocols E Barry, DJ DeAngelo, D Neuberg, K Stevenson, ML Loh, BL Asselin, ... Journal of clinical oncology 25 (7), 813-819, 2007 | 250 | 2007 |
| SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS L Malcovati, K Stevenson, E Papaemmanuil, D Neuberg, R Bejar, ... Blood, The Journal of the American Society of Hematology 136 (2), 157-170, 2020 | 239 | 2020 |
